4/AFiling Date: Oct 1, 2026

Resmed (RMD) 4/A: Farrell Michael J. transacted shares; Farrell Michael J. tr… (Oct 1, 2026)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0000943819-26-000078
Total Value$0
Trades2
Insiders1

Transaction Details

Farrell Michael J.
Chairman and CEO, Director·Indirect · Lisette and Michael Farrell Family Trust
ResMed Common Stock
Shares0
Price-
Total Value$0
Shares Owned After2.09K
Farrell Michael J.
Chairman and CEO, Director·Direct
ResMed Common Stock
Shares0
Price-
Total Value$0
Shares Owned After479.80K
Footnotes ▸

This amendment is being filed solely to update the number of shares beneficially owned by the Reporting Person following the transaction reported on the original Form 4 filed on September 10, 2026. The transaction reported on the original Form 4 is unchanged.

Post-Transaction Holdings

Farrell Michael J. · Chairman and CEO, Director
SecuritySharesChange
ResMed Common Stock481.89K-
Original SEC Filing Textexpand_more
=== SEC Form 4/A — Statement of Changes in Beneficial Ownership === Document Type: 4/A Period of Report: 2026-09-08 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: RESMED INC (RMD) CIK: 0000943819 --- Reporting Owner --- Name: Farrell Michael J. CIK: 0001485164 Role: Director, Officer (Chairman and CEO) --- Holdings --- [Holding #1] Security: ResMed Common Stock Ownership: D (Direct) Footnotes: [F1] This amendment is being filed solely to update the number of shares beneficially owned by the Reporting Person following the transaction reported on the original Form 4 filed on September 10, 2026. The transaction reported on the original Form 4 is unchanged. [Holding #2] Security: ResMed Common Stock Ownership: I (Indirect) --- Footnotes (Complete Index) --- F1: This amendment is being filed solely to update the number of shares beneficially owned by the Reporting Person following the transaction reported on the original Form 4 filed on September 10, 2026. The transaction reported on the original Form 4 is unchanged. --- Signature --- /s/ /s/ Lisa Beyer, attorney-in-fact for Mr. Farrell (2026-10-01)

keid analysis is for reference only and does not constitute investment advice.